Yes2Breathe Logo

ASTHMA CONTROL

RELIEVER RELIANCE

Reliever Reliance

If you believe that your blue reliever inhaler is the most important part of your Asthma treatment and you use it very often, you may be at risk of becoming over-reliant on that inhaler. Using your reliever 3 times or more a week can put you at risk of experiencing Asthma attacks more often. 10,21 The recently updated global recommendations overturn decades of Asthma care, highlighting the need to re-examine Asthma treatment. The guidelines state that although every person with Asthma should be prescribed a reliever to treat acute symptoms, you should also be using daily preventative treatment (a controller), even if you do not experience symptoms regularly. This strategy will ensure you do not become too reliant on your blue reliever. 10,21

The Reliever Over-Reliance Test

Using a SABA inhaler 3 or more times a week is an indicator of increased risk of Asthma attacks.

Experts co-developed a 5-item questionnaire to assess reliance.

Click below to view the Reliever Over-Reliance Test.

TAB 3_Call-to-action 1
Find out more

Controlled vs uncontrolled Asthma

Being in control of your condition can make you feel calmer and more at ease.

Tools for Asthma control

These useful resources can help you manage your Asthma.

Symptom control

This easy to use, quick tool can be used to check your Asthma control.

Important Notice:
Fraudulent WhatsApp and Facebook Group Impersonating AstraZeneca

Dear All,

Please be informed that AstraZeneca has become aware of illegitimate groups on social media platforms—including Instagram, WhatsApp, and Facebook—operating an illegal Ponzi scheme falsely claiming association with AstraZeneca. These schemes have no connection to AstraZeneca and are unlawfully using the AstraZeneca name and a fake bank account.

AstraZeneca is taking legal action to stop these activities.
We strongly advise you not to pay any fees or share any personal information with these groups, as they are entirely unaffiliated with AstraZeneca or its products.

Thank you for your attention.

AstraZeneca Pharmaceuticals (Pty) Ltd. South Africa Reg. No. 1992/005854/07
Building 2, Northdowns Office Park, 17 Georgian Crescent West, Bryanston, 2191, South Africa.
Private Bag X23, Bryanston, 2021, South Africa.
Tel: 011 797-6000. www.astrazeneca.com

Expiry date: 31 December 2025. Activity ID: ZA-6140.

Legal Notice and Terms | Cookies | Privacy Notice | Adverse Event Reporting